• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂的羟自由基清除反应活性

Hydroxyl radical scavenging reactivity of proton pump inhibitors.

作者信息

Simon Wolfgang Alexander, Sturm Ernst, Hartmann Hans-Jürgen, Weser Ulrich

机构信息

ALTANA Pharma AG, Byk Guldenstrasse 2, D 78464 Konstanz, Germany.

出版信息

Biochem Pharmacol. 2006 Apr 28;71(9):1337-41. doi: 10.1016/j.bcp.2006.01.009. Epub 2006 Feb 21.

DOI:10.1016/j.bcp.2006.01.009
PMID:16494850
Abstract

In addition to the established control of acid secretion of the class of proton pump inhibitors (PPI) reactivity from the pyridyl methyl sulphinyl benzimidazole type a second independent anti-inflammatory reactivity was observed in vitro. This inhibitory reactivity was clearly noticed using three different assays where the aggressive hydroxyl radicals were successfully trapped in a concentration dependent manner. There is unequivocal evidence that the proton pump inhibitors having the sulphoxide group are able to scavenge hydroxyl radicals which are generated during a Fenton reaction. By way of contrast, the corresponding thioethers were substantially less active. No detectable effect was seen in the superoxide radical scavenging system. In conclusion, pantoprazole as well as the other proton pump inhibitors have a pronounced inhibitory reactivity towards hydroxyl radicals.

摘要

除了已确定的质子泵抑制剂(PPI)类对吡啶基甲基亚磺酰基苯并咪唑型酸分泌的控制作用外,体外还观察到了第二种独立的抗炎反应性。使用三种不同的测定方法清楚地观察到了这种抑制反应性,在这些方法中,活性羟基自由基以浓度依赖的方式被成功捕获。有明确证据表明,具有亚砜基团的质子泵抑制剂能够清除芬顿反应过程中产生的羟基自由基。相比之下,相应的硫醚活性则低得多。在超氧自由基清除系统中未观察到可检测的效果。总之,泮托拉唑以及其他质子泵抑制剂对羟基自由基具有显著的抑制反应性。

相似文献

1
Hydroxyl radical scavenging reactivity of proton pump inhibitors.质子泵抑制剂的羟自由基清除反应活性
Biochem Pharmacol. 2006 Apr 28;71(9):1337-41. doi: 10.1016/j.bcp.2006.01.009. Epub 2006 Feb 21.
2
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.用静脉注射泮托拉唑替代口服质子泵抑制剂以有效控制卓艾综合征患者的胃酸分泌过多。
Am J Gastroenterol. 2001 Dec;96(12):3274-80. doi: 10.1111/j.1572-0241.2001.05325.x.
3
Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.泮托拉唑对大鼠肝微粒体中异源物代谢酶的影响:与其他质子泵抑制剂的比较。
Drug Metab Dispos. 1997 May;25(5):584-9.
4
Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.泮托拉唑与其他质子泵抑制剂对卓-艾综合征患者24小时胃内pH值及基础酸分泌的影响。
Gastroenterol Clin Biol. 2002 Apr;26(4):355-9.
5
Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.质子泵抑制剂对13C尿素呼气试验的掩盖作用取决于药物类型:奥美拉唑、泮托拉唑、兰索拉唑和埃索美拉唑之间的比较。
Aliment Pharmacol Ther. 2004 Jul 1;20(1):117-22. doi: 10.1111/j.1365-2036.2004.02021.x.
6
Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes.泮托拉唑在聚丙烯注射器中0.9%氯化钠注射液中的稳定性。
Am J Health Syst Pharm. 2005 Nov 15;62(22):2410-2. doi: 10.2146/ajhp050132.
7
Proton pump inhibitors: new drugs and indications.
Am Fam Physician. 1996 Jan;53(1):285-92.
8
[Proton pump inhibitors: Pantoprazole].
Nihon Rinsho. 2002 Feb;60 Suppl 2:655-60.
9
Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
Conn Med. 2004 Aug;68(7):435-8.
10
Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.雷贝拉唑:质子泵抑制剂在根除幽门螺杆菌中的作用。
Expert Rev Anti Infect Ther. 2005 Dec;3(6):863-70. doi: 10.1586/14787210.3.6.863.

引用本文的文献

1
Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway.兰索拉唑通过 p38 MAPK/ARE/Nrf2 通路保护肝细 胞免受顺铂诱导的氧化应激。
PLoS One. 2023 Jun 29;18(6):e0287788. doi: 10.1371/journal.pone.0287788. eCollection 2023.
2
Proton Pump Inhibitors Were Associated With Reduced Pseudocysts in Acute Pancreatitis: A Multicenter Cohort Study.质子泵抑制剂与急性胰腺炎假性囊肿减少相关:一项多中心队列研究。
Front Pharmacol. 2021 Dec 14;12:772975. doi: 10.3389/fphar.2021.772975. eCollection 2021.
3
Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway.
埃索美拉唑通过丝裂原活化蛋白激酶/核因子E2相关因子2/血红素加氧酶1途径减轻肺细胞中的炎症和纤维化反应。
J Inflamm (Lond). 2021 May 19;18(1):17. doi: 10.1186/s12950-021-00284-6.
4
Topical Esomeprazole Mitigates Radiation-Induced Dermal Inflammation and Fibrosis.局部用埃索美拉唑减轻放射性皮肤炎症和纤维化。
Radiat Res. 2019 Nov;192(5):473-482. doi: 10.1667/RR15398.1. Epub 2019 Aug 15.
5
Uroprotective effect of pantoprazole against cyclophosphamide-induced cystitis in mice.泮托拉唑对环磷酰胺诱导的小鼠膀胱炎的尿保护作用。
Support Care Cancer. 2019 Nov;27(11):4273-4281. doi: 10.1007/s00520-019-04731-2. Epub 2019 Mar 14.
6
Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.胆管癌与质子泵抑制剂使用之间的关联:一项巢式病例对照研究。
Front Pharmacol. 2018 Jul 3;9:718. doi: 10.3389/fphar.2018.00718. eCollection 2018.
7
Proton Pump Inhibitors in IPF: A Call for Clinical Trials.特发性肺纤维化中的质子泵抑制剂:呼吁开展临床试验。
Front Pharmacol. 2018 May 17;9:499. doi: 10.3389/fphar.2018.00499. eCollection 2018.
8
Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.抑酸治疗与感染风险:利弊分析
Clin Drug Investig. 2017 Jul;37(7):587-624. doi: 10.1007/s40261-017-0519-y.
9
Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model.埃索美拉唑在棉烟诱导的肺损伤模型中的治疗效果。
Front Pharmacol. 2017 Jan 26;8:16. doi: 10.3389/fphar.2017.00016. eCollection 2017.
10
Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.嗜酸性粒细胞性食管炎:与胃食管反流病的相互作用
Gastroenterol Clin North Am. 2014 Jun;43(2):243-56. doi: 10.1016/j.gtc.2014.02.004. Epub 2014 Mar 24.